TGR-1202 (Umbralisib) in Treatment Na ïve Patients With Chronic Lymphocytic Leukemia (CLL)

Condition:   Chronic Lymphocytic Leukemia Intervention:   Drug: Umbralisib Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   TG Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials